These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 4121172)

  • 1. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; Du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Mar; 5(1):415-20. PubMed ID: 4121172
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Sep; 5(3):1301-7. PubMed ID: 4125685
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ; Bach FH
    Transplant Proc; 1972 Sep; 4(3):307-10. PubMed ID: 4263510
    [No Abstract]   [Full Text] [Related]  

  • 4. The response of alloimmune human lymphocytes in mixed lymphocyte culture tests.
    Bondevik H; Thorsby E
    Transplant Proc; 1973 Dec; 5(4):1477-80. PubMed ID: 4272813
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse.
    Nabholz M; Vives J; Young HM; Meo T; Miggiano V; Rijnbeek A; Shreffler DC
    Eur J Immunol; 1974 May; 4(5):378-87. PubMed ID: 4277395
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of mixed lymphocyte culture response, HL-A histocompatibility antigens, and renal transplantation.
    Thompson JS; Flink RJ; Caldwell JL; Severson CD; Bonney WW
    Transplant Proc; 1973 Dec; 5(4):1763-9. PubMed ID: 4130081
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated lympholysis (CML) in the absence of LD2 mixed lymphocyte reaction and CML in the presence of SD1-SD2 identity in two HL-S-genotyped families.
    Mawas C; Sasportes M; Christen Y; Bernard A; Dausset J; Alter BJ; Bach ML
    Transplant Proc; 1973 Dec; 5(4):1683-9. PubMed ID: 4130077
    [No Abstract]   [Full Text] [Related]  

  • 9. The cellular immunity of mother versus child at delivery: sensitization in unidirectional mixed lymphocyte culture and subsequent 51-Cr-release cytotoxicity test.
    Bonnard GD; Lemos L
    Transplant Proc; 1972 Jun; 4(2):177-80. PubMed ID: 5034146
    [No Abstract]   [Full Text] [Related]  

  • 10. Sarcoidosis: correlation of delayed hypersensitivity, MLC reactivity and lymphocytotoxicity with disease activity.
    Broom BC; MacLaurin BP
    Clin Exp Immunol; 1973 Nov; 15(3):355-64. PubMed ID: 4271772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SD vs. LD antigens as targets for lymphocyte-mediated cytotoxicity: study of a family presenting a recombination event within the MHR.
    Bonnard GD; Chappuis M; Glauser A; Mempel W; Baumann P; Grosse-Wilde H; Albert ED
    Transplant Proc; 1973 Dec; 5(4):1679-82. PubMed ID: 4130076
    [No Abstract]   [Full Text] [Related]  

  • 12. The cellular recognition in vitro of antigens related to human histocompatibility.
    Eijsvoogel VP
    Semin Hematol; 1974 Jul; 11(3):305-24. PubMed ID: 4134543
    [No Abstract]   [Full Text] [Related]  

  • 13. The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man.
    Eijsvoogel VP; du Bois MJ; Meinesz A; Bierhorst-Eijlander A; Zeylemaker WP; Schellekens PT
    Transplant Proc; 1973 Dec; 5(4):1675-8. PubMed ID: 4130075
    [No Abstract]   [Full Text] [Related]  

  • 14. A second locus determining human MLC response: separate lymphocyte populations recognize the products of each different MLC-locus allele in allogeneic combinations.
    Thorsby E; Hirschberg H; Helgesen A
    Transplant Proc; 1973 Dec; 5(4):1523-8. PubMed ID: 4272817
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations upon DNA synthesis and the cytotoxic response of leucocytes after mixed culture and their relation to histocompatibility antigens in man.
    Pegrum GD; Evans CA; Middleton VL; Balfour IC
    Clin Exp Immunol; 1972 Nov; 12(3):357-63. PubMed ID: 4264648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lymphocyte proliferative responses by anti-HL-A alloantisera.
    Brochier J; Roitt IM; Festenstein H
    Eur J Immunol; 1974 Nov; 4(11):709-15. PubMed ID: 4279178
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetics of cell-mediated lympholysis in man.
    Geha RS; Malakian A; Geha O; Yunis E
    J Immunol; 1977 Apr; 118(4):1286-91. PubMed ID: 66285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of HL-A antibodies on lymphocyte transformation in vitro.
    Thorsby E; Bondevik H; Solheim BG
    Transplant Proc; 1973 Mar; 5(1):343-8. PubMed ID: 4266658
    [No Abstract]   [Full Text] [Related]  

  • 19. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of lymphocytes in vitro to reactions against cultured Burkitt's lymphoma cells.
    Golub SH; Hewetson JF; Svedmyr AJ; Klein G; Singh S
    Natl Cancer Inst Monogr; 1973 Jun; 37():25-32. PubMed ID: 4713782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.